A Phase 1/2 Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects with Metastatic Renal Cell Carcinoma [clinicaltrials_resource:d8c192a6b89a3b07e67a62c54d340217]
link [clinicaltrials_vocabulary:link]
A Phase 1/2 Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects with Metastatic Renal Cell Carcinoma [clinicaltrials_resource:d8c192a6b89a3b07e67a62c54d340217]
Bio2RDF identifier
d8c192a6b89a3b07e67a62c54d340217
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d8c192a6b89a3b07e67a62c54d340217
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:d8c192a6b89a3b07e67a62c54d340217
title
A Phase 1/2 Study of a Chimeri ...... etastatic Renal Cell Carcinoma
@en
type
label
A Phase 1/2 Study of a Chimeri ...... 192a6b89a3b07e67a62c54d340217]
@en